S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Cochlear Tops Newsweek's 2026 Most Trustworthy Healthcare List

For the second time in three years, Cochlear has captured the top spot in Newsweek’s World’s Most Trustworthy Companies ranking for the healthcare and life sciences sector. The designation arrives as the hearing implant manufacturer continues to emphasize its patient-first mission amidst a broader shift toward corporate accountability.

Cochlear Tops Newsweek's 2026 Most Trustworthy Healthcare List
Photo: Bio & News

The rankings, compiled in partnership with data firm Statista, rely on a methodology that blends public perception with hard data. Analysts evaluated roughly 200,000 corporate assessments from 65,000 participants across 20 countries, while cross-referencing these findings against more than 320,000 media mentions. This approach aims to measure the resilience and reliability of organizations in the eyes of their investors, staff, and customers.

Dig Howitt, Cochlear’s CEO and president, attributed the accolade to the company’s internal focus on the hearing journey of its recipients. Founded in 1981 by Professor Graeme Clark, the company has grown to support over 800,000 individuals globally. With more than A$3 billion invested in research and development, Cochlear maintains a workforce of 5,500 employees dedicated to advancing its implantable hearing technology. The latest recognition underscores the firm’s standing in a competitive market where technological reliability remains the primary metric for long-term stakeholder confidence.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!